Bone Cement: A New Filling Material for Bone Metastasis of Lung Cancer with EGFR Mutation

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2000035496

Enrollment

Unknown

Registered

2020-08-12

Start date

2020-09-01

Completion date

Unknown

Last updated

2020-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

lung cancer

Interventions

1:Bone cement

2:Bone cement loaded with EGFR-TKI targeted drugs

3:EGFR-TKI targeted drugs

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: (1) There is a history of lung cancer; (2) The diagnosis is confirmed by X-ray, CT, MRI or ECT; (3) EGFR mutation.

Exclusion criteria

Exclusion criteria: (1) Many underlying diseases; (2) Symptoms of nerve root or spinal cord compression; (3) Severe bone destruction.

Design outcomes

Primary

Measure	Time frame
progression free survival;overall survival;	—

Countries

China

Contacts

Public ContactHe Yayi

Shanghai Pulmonary Hospital Affiliated to Tongji University

2250601@qq.com+86 13818828623

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026